MedPath

Efficacy of ramosetron hydrochloride in male patients with diarrhea-predominant irritable bowel syndrome

Not Applicable
Conditions
Diarrhea-predominant irritable bowel syndrome
Registration Number
JPRN-UMIN000006663
Lead Sponsor
Shimane University Faculty of Medicine, Department of Gastroenterology and Hepatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who have bowel move disturbance by organic lesion such as IBD (UC and Crohn disease etc.) and cancer. 2) Patients suspected of obstruction in stomach and intestines, and with a history of total gastric resection or bowel resection but not appendectomy 3) Patients with serious complications (liver, kidney, heart, lung, circulatory, or metabolic disorder) 4) Patients with a history of drug allergy 5) Others, including patients who are unfit for the study as determined by the attending doctor 6) Patients who are taking polycarbophil calcium.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath